Explore the latest Editors’ picks from Journal of Antimicrobial Chemotherapy (JAC) and JAC-Antimicrobial Resistance (JAC-AMR). This month, two different studies look at the effect of COVID-19 on antimicrobial prescribing, therapeutic drug monitoring reveals the importance of considering obesity in ceftazidime dosing, and a survey of students in Zambia highlights high levels of self-medication with antibiotics. Also, find out how cholesterol-lowering drugs could help to treat invasive fungal infections.

In this article, Baroness Bennett of Manor Castle, BSAC-funded intern Katy Stokes, and Aziz Foundation-funded intern Zoheb Ali explore the connection between increases in AMR and practices of deforestation. They also scrutinise weak forest governance and the fraught relationship between deforesting states and private entities, calling for coordinated international action at the highest level to curb the global health and climate crises.

Understanding Antimicrobial Resistance (AMR) and the drivers for its development will help healthcare professionals work together to reduce its emergence and spread. It is well documented that the more we use antimicrobial agents, the more drug resistance will develop. Many National Dental Organisations* have come together to support the World AMR Awareness Week theme “Preventing Antimicrobial Resistance Together”.

With members in 40 nations, and over 100,000 learners in more than 200 countries, BSAC is a global network of medics, scientists and specialists, working with our members to ensure the availability of effective antimicrobial treatment for future generations. In this short article, we shine the spotlight on one of our members, Dr. Charles Narh, who is based at Deakin University, Australia.

The Global Health Network and British Society for Antimicrobial Chemotherapy (BSAC) have signed a Memorandum of Understanding (MoU) establishing a framework for collaboration that can maximise the impact of shared antimicrobial resistance education, policy and advocacy efforts.

Explore the latest Editors’ picks from Journal of Antimicrobial Chemotherapy (JAC) and JAC-Antimicrobial Resistance (JAC-AMR). In JAC, we have support for a new, shorter treatment regimen for visceral leishmaniasis, safety trial results for a new antifungal treatment and a report on remdesivir treatment for COVID-19 patients. And in JAC-AMR, 10 years of data from Peru show a worrying increase in resistance to shigellosis treatments and a report finds reduced cefiderocol activity in Pseudomonas aeruginosa with treatment-emergent resistance to ceftolozane/tazobactam.

Now in its second year, the BSAC Parliamentary Internship Programme offers a unique opportunity for two PhD students to work at the intersection of science and policy in the Office of Baroness Natalie Bennett. Following the success of our first cohort, we are pleased to announce our two new BSAC-funded interns: Lorna Flintham, and Katy Stokes.

Following the successful accreditation of 10 hospitals joining our Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS) in 2023, BSAC is excited to announce that we have opened applications for hospitals wishing to join the next tranche of GAMSAS clients starting the process in early 2024.